Market Cap 3.42M
Revenue (ttm) 0.00
Net Income (ttm) -2.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.61
Volume 17,500
Avg Vol 40,166
Day's Range N/A - N/A
Shares Out 341.74M
Stochastic %K 100%
Beta -1.43
Analysts Strong Buy
Price Target N/A

Company Profile

The Coretec Group Inc. engages in the development of silicon anode active materials for lithium-ion batteries and cyclohexasilane for electric vehicles, cleantech, and tech applications. The company was founded in 2002 and is headquartered in Ann Arbor, Michigan.

Industry: Computer Hardware
Sector: Technology
Phone: 866 916 0833
Address:
333 Jackson Plaza, Suite 460, Ann Arbor, United States
16driver
16driver May. 13 at 7:50 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177598422
0 · Reply
16driver
16driver May. 13 at 7:49 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177598363
0 · Reply
16driver
16driver May. 12 at 5:58 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177594200
0 · Reply
16driver
16driver May. 8 at 5:32 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177583115
0 · Reply
ATML
ATML May. 5 at 5:00 PM
$CRTG As we all know unless or until they file the necessary paperwork 10K, Qs to get updated we’re toast.
1 · Reply
16driver
16driver May. 5 at 3:11 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177570354
0 · Reply
16driver
16driver May. 5 at 3:10 PM
$CRTG “The work is being funded by Coretec itself, using Core Optics revenue. Partners supported work where the partner pays for testing, not Coretec. If a partner is testing Endurion materials, the partner pays for the testing, not Coretec. The failed DKME deal was not a blow to Endurion, because DKME was never the funding source for Endurion. DKME was a separate Korean industrial acquisition strategy.”
0 · Reply
16driver
16driver May. 5 at 3:09 PM
$CRTG “I had been asking myself a question for quite a while - Given that the patent on a method of CHS synthesis was granted in July of 2024, why hasn't the company made it more publicly known? But if all the suggested work on Endurion really is in process, AND we accept that CHS is an integral component of Endurion chemistry - then it might make sense that a patent award isn't converted into a press release if such a patent is part of something else they aren't talking about. So then my question might be who is paying for all this work, and was the failed DKME deal a blow to the plan?”
0 · Reply
16driver
16driver May. 4 at 6:07 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177568692
0 · Reply
16driver
16driver May. 4 at 2:22 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177565967
0 · Reply
Latest News on CRTG
No data available.
16driver
16driver May. 13 at 7:50 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177598422
0 · Reply
16driver
16driver May. 13 at 7:49 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177598363
0 · Reply
16driver
16driver May. 12 at 5:58 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177594200
0 · Reply
16driver
16driver May. 8 at 5:32 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177583115
0 · Reply
ATML
ATML May. 5 at 5:00 PM
$CRTG As we all know unless or until they file the necessary paperwork 10K, Qs to get updated we’re toast.
1 · Reply
16driver
16driver May. 5 at 3:11 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177570354
0 · Reply
16driver
16driver May. 5 at 3:10 PM
$CRTG “The work is being funded by Coretec itself, using Core Optics revenue. Partners supported work where the partner pays for testing, not Coretec. If a partner is testing Endurion materials, the partner pays for the testing, not Coretec. The failed DKME deal was not a blow to Endurion, because DKME was never the funding source for Endurion. DKME was a separate Korean industrial acquisition strategy.”
0 · Reply
16driver
16driver May. 5 at 3:09 PM
$CRTG “I had been asking myself a question for quite a while - Given that the patent on a method of CHS synthesis was granted in July of 2024, why hasn't the company made it more publicly known? But if all the suggested work on Endurion really is in process, AND we accept that CHS is an integral component of Endurion chemistry - then it might make sense that a patent award isn't converted into a press release if such a patent is part of something else they aren't talking about. So then my question might be who is paying for all this work, and was the failed DKME deal a blow to the plan?”
0 · Reply
16driver
16driver May. 4 at 6:07 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177568692
0 · Reply
16driver
16driver May. 4 at 2:22 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177565967
0 · Reply
16driver
16driver May. 4 at 2:21 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177565741
0 · Reply
16driver
16driver Apr. 27 at 1:43 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177541028
0 · Reply
16driver
16driver Apr. 25 at 9:09 PM
$CRTG KIB Plug Energy shares 11,415,525 @ 438 = 4,999,999,950 Acquisition date November 7, 2024. 16,000,000 @ 600 = 9,600,000,000 Acquisition date November 15, 2024. 6,542,056 @ 535 = 3,499,999,960 Acquisition date November 18, 2024. 8,000,000 @ 750 = 6,000,000,000 Acquisition date November 15, 2024. 41,957,581. 10,904,635 @ 610 = 6,651,827,350 Acquisition date January 15, 2025. 52,862,216 Won 30,751,827,260. They paid 30,751,827,260 won for those shares at the time. And selling now for 32,774,573,920 won. Figuring in time and any other costs, I think they probably lost money.
0 · Reply
16driver
16driver Apr. 24 at 8:34 AM
$CRTG Juststoppingby Re: iamthe walrus post# 46163 Thursday, 04/23/2026 9:49:13 PM Both companies were in the bidding; only Deokyang & Wolf qualified, and Energine did not qualify, but offered more per share. On April 17, 2026, Energine received a proposal for a private contract from DKME Inc. On April 18, the two parties exchanged draft contract documents. On April 19, the final contract was signed. And that made Deokyang & Wolf offer the same amount per share. It looks like this will close by May 11th
1 · Reply
16driver
16driver Apr. 24 at 8:33 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177518185
0 · Reply
16driver
16driver Apr. 20 at 12:57 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177517618
0 · Reply
16driver
16driver Apr. 20 at 12:56 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177517532
0 · Reply
16driver
16driver Apr. 20 at 12:55 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177517480
0 · Reply
16driver
16driver Apr. 20 at 4:45 AM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177517141
0 · Reply
16driver
16driver Apr. 19 at 10:48 PM
$CRTG So can the DKME stake be included in the 'coming-current' SEC filings? Directly? No. Coretec cannot list DKME as an asset because it no longer owns the DKME shares. Indirectly? Yes — and this is important. Coretec must disclose: - The May 16, 2025 share exchange - The removal of DKME from its balance sheet - The retirement of the Series D preferred shares - The strategic rationale for the transaction - Any ongoing relationship with DKME Inc. or Quantum - Any intent to reacquire DKME Inc. in the future This is required under: - ASC 850 (related-party transactions) - Reg S-K Item 303 (MD&A) - Reg S-K Item 101 (Business) - Reg S-K Item 105 (Risk Factors) So DKME will appear in the filings — but as a material past transaction, not a current asset.
0 · Reply
16driver
16driver Apr. 19 at 10:47 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177515932
0 · Reply
16driver
16driver Apr. 19 at 10:46 PM
$CRTG https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177515924
0 · Reply